Zepbound (tirzepatide) availability: where to get it
Reviewed by Yael Cooperman, MD, Ro,
Written by Felix Gussone, MD, Ro
last updated: Dec 21, 2023
1 min read
Here's what we'll cover
When tirzepatide was first released as a diabetes drug under the brand name Mounjaro, experts and patients noticed how effective the medication was for weight loss. While tirzepatide was initially only approved by the FDA for treating diabetes, the FDA has now approved Eli Lilly’s new drug Zepbound, which has the same active ingredient as Mounjaro, for chronic weight management. We spoke with Dr. Felix Gussone about Zepbound (tirzepatide) availability and where to find it.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Weight loss
Get your personalized GLP-1 recommendation
based on cost, availability, and weight loss goals.
Tirzepatide availability
Since its approval as a treatment for overweight and obesity under the brand name Zepbound, tirzepatide has become widely available at major retailers and pharmacies. Zepbound does require a prescription from a US-licensed healthcare provider, so if you’re looking to get the medication, the first step is to make an appointment with your doctor or go through a telehealth platform like the Ro Body program. Ro offers a comprehensive weight loss management system, including visits with healthcare professionals who can evaluate your eligibility for weight loss medications and create a personally-tailored program to help you lose the weight and keep it off.
While shortages have plagued many weight loss medications, making treatment problematic for many, Eli Lilly has committed to building a new manufacturing plant in order to increase production and reduce the risk of shortages to ensure patients can get the medication they need. Once you have a prescription in hand, you should be able to find Zepbound (tirzepatide) at your local pharmacy, including CVS, Rite Aid, Wegman’s, Walgreens, Safeway, Costco, and more.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Chen, E. & Garde, D. (2023). Eli Lilly Gets FDA Approval to Sell Mounjaro as Obesity Drug Called Zepbound. STAT. Retrieved Nov. 9, 2023 from https://www.statnews.com/2023/11/08/obesity-eli-lilly-mounjaro-zepbound-fda/
Gardner, J. (2023). Lilly Plans New $2.5B Manufacturing Plant as Obesity Drug Demand Ramps Up. BioPharma Dive. Retrieved from https://www.biopharmadive.com/news/lilly-zepbound-mounjaro-new-manufacturing-plant-germany/700150/
Tirrell, M. (2023). FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, Zepbound. CNN Health. Retrieved from https://www.cnn.com/2023/11/08/health/zepbound-mounjaro-fda-approval-obesity/index.html
U.S. Food and Drug Administration (FDA). (2023). FDA Approves New Medication for Chronic Weight Management. Retrieved Nov. 8, 2023 from https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
How we reviewed this article
Current version
Felix Gussone, MD
Yael Cooperman, MD
About the medical reviewer
